Search - tctmd.com

Displaying 901 - 920 of 2724

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: FFR in a Diagnostic-Only Lab and PCI Without On-site Surgery

August 03, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Daily News

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

L.A. McKeown

July 29, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Industry News

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

July 28, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Daily News

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Todd Neale

July 23, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Daily News

In Medicare Population, Early Survival Benefit of EVAR Lost After 3 Years

July 23, 2015

News Daily News

Study Sheds Light on Use of Stress Testing Post-PCI in VA System

L.A. McKeown

July 22, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

Advertisement

Conversations in Cardiology: FFR in a Diagnostic-Only Lab and PCI Without On-site Surgery

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

COMPARE: EES Maintains Advantage Over PES at 5 Years

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Lilly Provides Update on Evacetrapib Phase 3 Trial

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

In Medicare Population, Early Survival Benefit of EVAR Lost After 3 Years

Study Sheds Light on Use of Stress Testing Post-PCI in VA System

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

DES, BMS Both Suitable for Treating Patients With SVG Lesions

Meta-analysis Confirms Safety of PCI without Surgical Backup

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content